Xbiotech (XBIT): Director received 79K units

79K

Derivative units

Traded

Oct 1, 2025

Filed

Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 24, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“XBiotech Inc. (“XBiotech” or the “Company”) files this Form 8-K/A solely to clarify information regarding director Craig Rademaker’s position at the private equity firm referenced in the first sentence of the third paragraph of the June 24, 2025 Form 8-K previously filed by the Company.”
2. Oct 1, 2025Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On October 2, 2025, John Simard and XBiotech, Inc. (the “Company”) entered into an Executive Employment Agreement (the “Agreement”), with an effective date of October 1, 2025, to replace and supersede all prior employment agreements between Mr. Simard and the Company.”

What came next

1. Dec 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the Board of Directors beginning on December 5, 2025 of his intent to retire from his role as President and Chief Executive Officer of the Company, effective as of December 8, 2025.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Xbiotech

For Xbiotech, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XBIT page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Xbiotech

• SEC Form 4Nov 13, 2026
• SEC Form 4Oct 28, 2026

Everything OQRO holds on this company is on its XBIT page.